Also listed on Isis Pharmaceuticals, Inc., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Jan 9, 2034 · High confidence
20-year base term ends Jan 9, 2034
Held by Biogen Ma Inc.
Filed Jul 9, 2015 as application 14/760,171 · Granted Mar 27, 2018
Base term, 20 years from filing
Today
2014
2034
Clock starts
Jan 9, 2014
Jan 9, 2014
Term ends
Jan 9, 2034
Jan 9, 2034
Granted
Mar 27, 2018
Mar 27, 2018
base term
fee events
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
3
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jan 9, 2014, when application PCT/US2014/010930, the earliest non-provisional in its chain, was filed (this one was filed Jul 9, 2015) | Jan 9, 2034 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jan 9, 2034 | High confidence |
This family
| Application PCT/US2014/010930 | PCT application no patent term | no patent term |
| US 9,926,559 | this patent Jan 2034 | Jan 2034 |
| Application 15/907,970 | Abandoned not computed | not computed |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Feb 22, 2016 Reel 37880, frame 409 | Isis Pharmaceuticals, Inc. | Ionis Pharmaceuticals, Inc. | Change of Name |
| Oct 18, 2016 Reel 40415, frame 295 | Ionis Pharmaceuticals, Inc. | Biogen Ma Inc. | Assignment of Assignor's Interest |
| May 20, 2026 Reel 74711, frame 207 | Bennett, C. Frank; Hung, Gene; Rigo, Frank | Isis Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Jan 2034
Term ends Jan 9, 2034. Maintenance fees still fall due before then
Citations
71
later US patents cite this one
That is top 5% of utility patents granted in 2018 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.